Ocugen (OCGN) Cash from Financing Activities (2014 - 2026)

Ocugen (OCGN) posted Cash from Financing Activities of $35.0 million for Q1 2026, up 1749100.0% on a QoQ basis from $2000.0 in Q4 2025, and up 2909.96% year-over-year from $1.2 million in Q1 2025.

Ocugen (OCGN) Cash from Financing Activities (2014 - 2026) Analysis & Trends

Ocugen's Cash from Financing Activities history runs 13 years deep, the most recent figure standing at $35.0 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 2909.96% year-over-year to $35.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.6 million (down 16.0% YoY) and the FY2025 annual result came in at $17.3 million, down 73.28% from the prior year.
  • Cash from Financing Activities was $35.0 million for Q1 2026 at Ocugen, up from $2000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $50.1 million in Q1 2022 and bottomed at -$1.2 million in Q1 2025.
  • A 5-year average of $11.6 million and a median of $962000.0 in 2022 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 188475.0% — and 2025, when it plunged 758.62%.
  • Ocugen's Cash from Financing Activities stood at $8.2 million in 2022, then tumbled by 99.8% to $16000.0 in 2023, then jumped by 188475.0% to $30.2 million in 2024, then tumbled by 99.99% to $2000.0 in 2025, then soared by 1749100.0% to $35.0 million in 2026.
  • Business Quant data shows OCGN's Cash from Financing Activities at $35.0 million in Q1 2026, $2000.0 in Q4 2025, and $18.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Ocugen 63.79 Mn 63.79 Mn - 34.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 34.98 Mn
Mar 31, 2026 34.98 Mn
Dec 31, 2025 2,000.00
Dec 31, 2025 2,000.00
Sep 30, 2025 18.51 Mn
Sep 30, 2025 18.51 Mn
Jun 30, 2025 61,000.00
Jun 30, 2025 61,000.00
Mar 31, 2025 -1.25 Mn
Mar 31, 2025 -1.25 Mn
Dec 31, 2024 30.17 Mn
Dec 31, 2024 30.17 Mn
Sep 30, 2024 34.79 Mn
Sep 30, 2024 34.79 Mn
Jun 30, 2024 45,000.00
Jun 30, 2024 45,000.00
Mar 31, 2024 -145,000.00
Mar 31, 2024 -145,000.00
Dec 31, 2023 16,000.00
Dec 31, 2023 16,000.00